Vaccine, rubella

Generic Medicine Info
Indications and Dosage
Active immunisation against rubella
Adult: Given as a combination with measles and mumps vaccines: 19-49 yr: 1 or 2 vaccination doses may be used, for adults ≥50 yr: only 1 vaccination dose is required.
Child: Given as a combination with measles and mumps vaccines: ≥12 mth: 2 doses of 0.5 ml. 1st dose is usually given after first birthday (recommended age: 12-15 mth old) and 2nd dose at 3-5 yr of age prior to school entry. Doses should be separated by at least 4 wk. May be given at any age if routine admin has been omitted. Immunisation dose given before 12 mth of age may not be counted.
Pregnancy. Hypersensitivity. Severe primary immunodeficiency, current treatment with chemotherapy or radiotherapy and within 6 mth of stopping such therapy, solid organ transplant receiving immunosuppressants, bone marrow transplant and for at least 12 mth after stopping immunosuppressive therapy, patients on high-dose systemic corticosteroids, HIV patients with immunosuppression.
Special Precautions
Women of child-bearing age should be vaccinated if they are seronegative; those who are found to be seronegative during pregnancy should be vaccinated in the early postpartum period. Not advisable to become pregnant within 1 mth of vaccination. Not recommended for children <1 yr. Allow alcohol or disinfectant that is used for skin cleansing to evaporate before vaccination to prevent inactivation of live vaccines.
Adverse Reactions
Skin rashes, pharyngitis, fever, and lymphadenopathy; arthralgia and arthritis may occur.
Parenteral/SC: C (FDA Pregnancy Category C applies in combination w/ measles & mumps vaccines.)
Drug Interactions
Not to be given within 1 mth of admin of other live vaccines. Live vaccines should only be given at least 3 wk before or after the use of immunoglobulin.
Description: Rubella vaccines are used for active immunisation against rubella also known as German measles. Symptoms of rubella infection are generally mild except in the early stages of pregnancy when it leads to fetal damage in most infants.
Store at 2-8°C.
MIMS Class
Vaccines, Antisera & Immunologicals
Disclaimer: This information is independently developed by MIMS based on Vaccine, rubella from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in